Qualicaps, a subsidiary of Mitsubishi Chemical, specializes in the production of high-quality two-piece hard capsules and pharmaceutical processing equipment. Their capsules, including the Quali-G™ gelatin capsules and Quali-V® hypromellose capsules, are designed to meet stringent pharmaceutical standards while offering versatility for both oral and inhalation administration. The company emphasizes the importance of performance, stability, and patient ease-of-use, ensuring that their products are suitable for a wide range of applications, including moisture-sensitive active pharmaceutical ingredients (APIs). Additionally, Qualicaps provides a comprehensive suite of machinery, such as capsule filling and inspection machines, which are engineered to enhance productivity and maintain high-quality standards in pharmaceutical manufacturing.

Innovation is at the core of Qualicaps' operations, as they continuously explore new materials and technologies to improve drug delivery and bioavailability. The company has a rich history of pioneering advancements in the capsule industry, being the first to introduce features like self-locking structures and preservative-free formulations. Their commitment to research and development has led to the creation of specialized capsules for dry powder inhalers and the development of advanced machinery, such as laser printing machines that enhance product security and detail. By focusing on both the present and future needs of healthcare, Qualicaps aims to lead the way in the evolution of pharmaceutical delivery systems.

United States

Qualicaps manufactures empty two-piece capsules (gelatin and hypromellose) and encapsulation equipment under cGMP regulations for use by pharmaceutical, OTC and dietary-supplement manufacturers.

Qualicaps (Mitubishi Chemical)

Company Details